Oryzon Genomics
Oryzon Genomics Logo
About Oryzon Genomics
Oryzon Genomics SA is a clinical stage biopharmaceutical company focused on the discovery and development of epigenetics-based therapeutics. The company develops innovative personalized medicines for patients with cancer and central nervous system disorders, leveraging its epigenetic platform to identify and validate biomarkers and therapeutic targets. Its clinical pipeline includes compounds for oncology, CNS, and other diseases.
Address
Sant Ferran 74,
Cornellà de Llobregat, 08940
Spain
Year founded
2000
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
